ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

210
Analysis
Health Care • India
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
•22 Dec 2018 06:01

EM Relative Strength Is Bottoming: Overweight

Relative strength for MSCI EM is bottoming vs. MSCI EAFE despite continued global equity market weakness.  Although the MSCI EM's price index...

Logo
1.2k Views
Share
bearish•MSCI ACWI Index
•20 Dec 2018 22:08

Global Markets Deteriorating...Except EM

With U.S. markets stumbling, the MSCI ACWI index is breaking down to new lows: defensive Sectors remain attractive. Relative to MSCI ACWI however,...

Logo
1k Views
Share
bearish•Aurobindo Pharma
•11 Dec 2018 02:50

India Generic Drugs: US Antitrust Inquiry Widens

The US government's antitrust investigation of the generic drug industry has been quiet for more than a year and has resurfaced with a...

Share
•05 Nov 2018 22:59

EM Strategy: Brazil Breaking Out, EM Energy Remains Attractive

While the MSCI EM index remains in a well-defined downtrend, and we continue to recommend selectivity, we highlight several investable themes and...

Logo
622 Views
Share
•01 Oct 2018 05:35

EM Strategy: Russia and Thailand Bullishly Inflecting; Pullback Opportunity in India

This report highlights actionable themes across the EM universe, including: bullish inflections in the Russian and Thai markets, and a pullback...

Logo
559 Views
Share
x